STLN
Starling Oncology, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:49:33 AM EST
3.34USD+4.375%(+0.14)300,576
Pre-marketNov 19, 2026 9:29:30 AM EST
3.25USD+1.562%(+0.05)
STLN Financials
In Q3 FY 2026 (ended ), Starling Oncology, Inc. Common Stock (STLN) reported revenue of $169.77M, net income of −$15.75M, operating cash flow of $10.14M, and assets of $187.77M (filed ).
Loading financial statements…